Evidence map›Paper›PMID 40429634›Full record

ArticleInternational journal of molecular sciences2025

Characterization of the Antiproliferative and Antimetastatic Properties of

Hazhmat Ali, Shelan Rasool, Muhammad Bello Saidu, Péter Germán, Gábor J Szebeni, Enikő Szabó, Dóra Rédei, Judit Hohmann, István Zupkó

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Hazhmat AliInstitute of Pharmacodynamics and Biopharmacy, University of Szeged, 6720 Szeged, Hungary.ORCID 0000-0002-2553-8443
Shelan RasoolInstitute of Pharmacodynamics and Biopharmacy, University of Szeged, 6720 Szeged, Hungary.ORCID 0009-0005-1740-1411
Muhammad Bello SaiduInstitute of Pharmacognosy, University of Szeged, 6720 Szeged, Hungary.
Péter GermánInstitute of Pharmacodynamics and Biopharmacy, University of Szeged, 6720 Szeged, Hungary.
Gábor J SzebeniLaboratory of Functional Genomics, Core Facility, HUN-REN Biological Research Centre, 6726 Szeged, Hungary.ORCID 0000-0002-6998-5632
Enikő SzabóLaboratory of Functional Genomics, Core Facility, HUN-REN Biological Research Centre, 6726 Szeged, Hungary.
Dóra RédeiInstitute of Pharmacognosy, University of Szeged, 6720 Szeged, Hungary.ORCID 0000-0002-5013-247X
Judit HohmannInstitute of Pharmacognosy, University of Szeged, 6720 Szeged, Hungary.
István ZupkóInstitute of Pharmacodynamics and Biopharmacy, University of Szeged, 6720 Szeged, Hungary.

Funding

Hungarian National Science and Research Fund 135845Hungarian National Science and Research Fund 143690Ministry of Culture and Innovation of Hungary TKP2021-EGA-32Open Access Fund of the University of Szeged 7704
6 · The paper itself

Abstract

The current study examined the in vitro antineoplastic potentials of centrapalus coumarin F (CCF) obtained from aerial parts of

Indexed as

Antineoplastic Agents, PhytogenicCell ProliferationCoumarinsPlant ExtractsTerpenesApoptosisCell Line, TumorCell MovementFemaleHeLa CellsHumansNeoplasm MetastasisUterine Cervical NeoplasmsAntineoplastic Agents, PhytogenicCoumarinsPlant ExtractsTerpenesantimetastaticantiproliferativecentrapalus coumarin FCentrapalus pauciflorus

Identifiers

PMID40429634
PMCPMC12111111

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.